Product Code: ETC13221809 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Benign Prostatic Hyperplasia Devices Market was valued at USD 3.8 Billion in 2024 and is expected to reach USD 6.5 Billion by 2031, growing at a compound annual growth rate of 7.88% during the forecast period (2025-2031).
The global benign prostatic hyperplasia (BPH) devices market is experiencing steady growth due to the increasing prevalence of BPH among aging male populations worldwide. BPH devices are used for minimally invasive procedures such as transurethral resection of the prostate (TURP) and prostatic artery embolization (PAE) to alleviate symptoms like urinary retention and frequent urination. Key market players are focusing on technological advancements to develop more efficient and safer devices, driving market growth. North America holds a significant share in the global BPH devices market, followed by Europe and Asia Pacific. Factors such as rising healthcare expenditure, increasing awareness about minimally invasive procedures, and a growing geriatric population are expected to further propel market expansion in the coming years.
The Global Benign Prostatic Hyperplasia (BPH) Devices Market is experiencing growth due to the increasing prevalence of BPH among aging male populations, advancements in minimally invasive procedures, and rising awareness about available treatment options. Key trends include the development of innovative technologies such as laser therapy, prostatic urethral lift (PUL) devices, and water vapor therapy, offering less invasive and more effective treatment solutions for patients. Opportunities in the market lie in expanding into emerging markets with a growing geriatric population, strategic partnerships between medical device companies and healthcare providers, and ongoing research and development efforts to enhance the efficacy and safety of BPH devices. Overall, the market is poised for further expansion driven by technological advancements and increasing demand for minimally invasive treatment options for BPH.
In the Global Benign Prostatic Hyperplasia (BPH) Devices Market, some key challenges include regulatory hurdles, limited awareness among patients, and the presence of alternative treatment options. Regulatory approvals can be time-consuming and costly, delaying market entry for new devices. Additionally, the lack of awareness among patients about BPH devices and their benefits can hinder adoption rates. Moreover, the availability of alternative treatment options such as medications or surgical procedures poses competition to BPH devices. Healthcare providers and manufacturers in this market must navigate these challenges by investing in education and awareness campaigns, streamlining regulatory processes, and innovating to differentiate their devices from existing treatment options.
The Global Benign Prostatic Hyperplasia (BPH) Devices Market is primarily driven by the increasing prevalence of BPH among aging male populations worldwide. The rising awareness about BPH and the availability of advanced diagnostic and treatment options are also significant drivers of market growth. Technological advancements in minimally invasive procedures such as laser therapy, prostatic stents, and water ablation devices have further fueled market expansion. Additionally, the growing demand for effective and efficient BPH treatment options, coupled with favorable reimbursement policies in developed countries, is boosting the adoption of BPH devices. Furthermore, strategic collaborations and partnerships among key market players to develop innovative devices and expand their product portfolios are contributing to the market`s growth trajectory.
Government policies related to the Global Benign Prostatic Hyperplasia (BPH) Devices Market primarily focus on regulatory approval processes for medical devices, reimbursement policies, and healthcare funding initiatives. Regulatory bodies such as the FDA in the United States and the CE Mark in Europe play a crucial role in ensuring the safety and efficacy of BPH devices before they can be marketed. Reimbursement policies vary by country and impact the adoption of BPH devices by healthcare providers and patients. Additionally, government-funded healthcare systems may influence the accessibility and affordability of BPH devices for patients. Overall, government policies in the Global BPH Devices Market aim to balance innovation, patient safety, and cost-effectiveness to promote the development and utilization of advanced medical technologies for the treatment of BPH.
The Global Benign Prostatic Hyperplasia (BPH) Devices Market is expected to witness significant growth in the coming years due to factors such as the increasing prevalence of BPH among aging male populations, technological advancements in minimally invasive treatment options, and rising awareness about the benefits of early diagnosis and treatment. The market is likely to be driven by the development of innovative devices such as laser therapy systems, prostatic stents, and water vapor therapy devices that offer effective and less invasive treatment options for BPH. Additionally, the growing demand for outpatient procedures and the focus on improving patient outcomes and quality of life are expected to contribute to the market`s expansion. Overall, the Global BPH Devices Market is poised for steady growth in the forecast period.
In the Global Benign Prostatic Hyperplasia Devices Market, Asia is poised for significant growth driven by the increasing prevalence of BPH in aging populations and rising awareness about minimally invasive treatment options. North America leads in market share due to advanced healthcare infrastructure and high adoption rates of technologically advanced BPH devices. Europe follows closely with a strong emphasis on research and development, leading to innovative device offerings. In the Middle East and Africa region, the market is steadily growing as healthcare facilities enhance their capabilities in treating BPH. Latin America is also witnessing growth, supported by improving healthcare infrastructure and increasing healthcare expenditure. Overall, the global BPH devices market is set to expand across all regions, with varying rates of growth driven by factors specific to each region.
Global Benign Prostatic Hyperplasia Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Benign Prostatic Hyperplasia Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Benign Prostatic Hyperplasia Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Benign Prostatic Hyperplasia Devices Market - Industry Life Cycle |
3.4 Global Benign Prostatic Hyperplasia Devices Market - Porter's Five Forces |
3.5 Global Benign Prostatic Hyperplasia Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Benign Prostatic Hyperplasia Devices Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.7 Global Benign Prostatic Hyperplasia Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Benign Prostatic Hyperplasia Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Benign Prostatic Hyperplasia Devices Market Trends |
6 Global Benign Prostatic Hyperplasia Devices Market, 2021 - 2031 |
6.1 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Transurethral Resection of the Prostate (TURP), 2021 - 2031 |
6.1.3 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Prostatic Urethral Lift (PUL), 2021 - 2031 |
6.1.4 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Prostatectomy, 2021 - 2031 |
6.1.5 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Laser Surgery, 2021 - 2031 |
6.1.6 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Transurethral Microwave Therapy (TUMT), 2021 - 2031 |
6.1.7 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Transurethral Needle Ablation of the Prostate (TUNA), 2021 - 2031 |
6.1.8 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Prostatic Stenting/Implants, 2021 - 2031 |
6.1.9 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.2.3 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.2.4 Global Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Benign Prostatic Hyperplasia Devices Market, Overview & Analysis |
7.1 North America Benign Prostatic Hyperplasia Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
7.4 North America Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Benign Prostatic Hyperplasia Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Benign Prostatic Hyperplasia Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
8.4 Latin America (LATAM) Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Benign Prostatic Hyperplasia Devices Market, Overview & Analysis |
9.1 Asia Benign Prostatic Hyperplasia Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
9.4 Asia Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Benign Prostatic Hyperplasia Devices Market, Overview & Analysis |
10.1 Africa Benign Prostatic Hyperplasia Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
10.4 Africa Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Benign Prostatic Hyperplasia Devices Market, Overview & Analysis |
11.1 Europe Benign Prostatic Hyperplasia Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
11.4 Europe Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Benign Prostatic Hyperplasia Devices Market, Overview & Analysis |
12.1 Middle East Benign Prostatic Hyperplasia Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
12.4 Middle East Benign Prostatic Hyperplasia Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Benign Prostatic Hyperplasia Devices Market Key Performance Indicators |
14 Global Benign Prostatic Hyperplasia Devices Market - Export/Import By Countries Assessment |
15 Global Benign Prostatic Hyperplasia Devices Market - Opportunity Assessment |
15.1 Global Benign Prostatic Hyperplasia Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Benign Prostatic Hyperplasia Devices Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
15.3 Global Benign Prostatic Hyperplasia Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Benign Prostatic Hyperplasia Devices Market - Competitive Landscape |
16.1 Global Benign Prostatic Hyperplasia Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Benign Prostatic Hyperplasia Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |